Anti-cancer pyrimidines in diverse scaffolds

A review of patent literature

Ramandeep Kaur, Prabhkirat Kaur, Sahil Sharma, Gurpreet Singh, Samir Mehndiratta, Preet M.S. Bedi, Kunal Nepali

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Pyrimidine ring is the building unit of DNA and RNA and thus pyrimidine based chemical architectures exhibit diverse pharmacological activities. Among the reported medicinal attributes of pyrimidines, anticancer activity is the most extensively reported. The anticancer potential of pyrimidines in fused scaffolds has also been evidenced through number of research article and patent literature. The pyrimidines based scaffolds have exerted their cell killing effects through varied mechanisms which indicate their potential to interact with diverse en-zymes/targets/receptors. This review article strictly focuses on the patent literature from 2009 onwards. The structure of the potent compounds, their IC50 values, models/assays used for the anticancer evaluation and the enzymes/ receptors/ targets involved have been presented in this compilation. Significant number of patents i.e. 59 have been published on pyrimidine based anticancer agents from 2009-2014 (from 2009 through the present date) which clearly indicate that this heterocycle is an area of focus at present for researchers all over the globe. Moreover, out of the 59 patents published during this period, 32 have been published from 2012 onwards which further highlights the present interest of the researcher towards pyrimidine based anticancer agents. The promising activity displayed by these pyrimidine based scaffolds clearly places them in fore-front as potential future drug candidates. The present compilation can be extremely beneficial for the medicinal chemists working on design and synthesis of anticancer drugs.

Original languageEnglish
Pages (from-to)23-71
Number of pages49
JournalRecent Patents on Anti-Cancer Drug Discovery
Volume10
Issue number1
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Pyrimidines
Patents
Literature
Neoplasms
Antineoplastic Agents
Research Personnel
Pharmaceutical Preparations
Inhibitory Concentration 50
pyrimidine
Pharmacology
RNA
DNA
Enzymes
Research

Keywords

  • Anticancer
  • Chemotherapeutic agents
  • Heterocycles
  • Medicinal
  • Patent
  • Pyrimidine

ASJC Scopus subject areas

  • Oncology
  • Drug Discovery
  • Cancer Research
  • Pharmacology (medical)

Cite this

Kaur, R., Kaur, P., Sharma, S., Singh, G., Mehndiratta, S., Bedi, P. M. S., & Nepali, K. (2015). Anti-cancer pyrimidines in diverse scaffolds: A review of patent literature. Recent Patents on Anti-Cancer Drug Discovery, 10(1), 23-71.

Anti-cancer pyrimidines in diverse scaffolds : A review of patent literature. / Kaur, Ramandeep; Kaur, Prabhkirat; Sharma, Sahil; Singh, Gurpreet; Mehndiratta, Samir; Bedi, Preet M.S.; Nepali, Kunal.

In: Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, No. 1, 01.01.2015, p. 23-71.

Research output: Contribution to journalArticle

Kaur, R, Kaur, P, Sharma, S, Singh, G, Mehndiratta, S, Bedi, PMS & Nepali, K 2015, 'Anti-cancer pyrimidines in diverse scaffolds: A review of patent literature', Recent Patents on Anti-Cancer Drug Discovery, vol. 10, no. 1, pp. 23-71.
Kaur R, Kaur P, Sharma S, Singh G, Mehndiratta S, Bedi PMS et al. Anti-cancer pyrimidines in diverse scaffolds: A review of patent literature. Recent Patents on Anti-Cancer Drug Discovery. 2015 Jan 1;10(1):23-71.
Kaur, Ramandeep ; Kaur, Prabhkirat ; Sharma, Sahil ; Singh, Gurpreet ; Mehndiratta, Samir ; Bedi, Preet M.S. ; Nepali, Kunal. / Anti-cancer pyrimidines in diverse scaffolds : A review of patent literature. In: Recent Patents on Anti-Cancer Drug Discovery. 2015 ; Vol. 10, No. 1. pp. 23-71.
@article{10176beb59c349deb10c0f7142d2c8c7,
title = "Anti-cancer pyrimidines in diverse scaffolds: A review of patent literature",
abstract = "Pyrimidine ring is the building unit of DNA and RNA and thus pyrimidine based chemical architectures exhibit diverse pharmacological activities. Among the reported medicinal attributes of pyrimidines, anticancer activity is the most extensively reported. The anticancer potential of pyrimidines in fused scaffolds has also been evidenced through number of research article and patent literature. The pyrimidines based scaffolds have exerted their cell killing effects through varied mechanisms which indicate their potential to interact with diverse en-zymes/targets/receptors. This review article strictly focuses on the patent literature from 2009 onwards. The structure of the potent compounds, their IC50 values, models/assays used for the anticancer evaluation and the enzymes/ receptors/ targets involved have been presented in this compilation. Significant number of patents i.e. 59 have been published on pyrimidine based anticancer agents from 2009-2014 (from 2009 through the present date) which clearly indicate that this heterocycle is an area of focus at present for researchers all over the globe. Moreover, out of the 59 patents published during this period, 32 have been published from 2012 onwards which further highlights the present interest of the researcher towards pyrimidine based anticancer agents. The promising activity displayed by these pyrimidine based scaffolds clearly places them in fore-front as potential future drug candidates. The present compilation can be extremely beneficial for the medicinal chemists working on design and synthesis of anticancer drugs.",
keywords = "Anticancer, Chemotherapeutic agents, Heterocycles, Medicinal, Patent, Pyrimidine",
author = "Ramandeep Kaur and Prabhkirat Kaur and Sahil Sharma and Gurpreet Singh and Samir Mehndiratta and Bedi, {Preet M.S.} and Kunal Nepali",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "10",
pages = "23--71",
journal = "Recent Patents on Anti-Cancer Drug Discovery",
issn = "1574-8928",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Anti-cancer pyrimidines in diverse scaffolds

T2 - A review of patent literature

AU - Kaur, Ramandeep

AU - Kaur, Prabhkirat

AU - Sharma, Sahil

AU - Singh, Gurpreet

AU - Mehndiratta, Samir

AU - Bedi, Preet M.S.

AU - Nepali, Kunal

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pyrimidine ring is the building unit of DNA and RNA and thus pyrimidine based chemical architectures exhibit diverse pharmacological activities. Among the reported medicinal attributes of pyrimidines, anticancer activity is the most extensively reported. The anticancer potential of pyrimidines in fused scaffolds has also been evidenced through number of research article and patent literature. The pyrimidines based scaffolds have exerted their cell killing effects through varied mechanisms which indicate their potential to interact with diverse en-zymes/targets/receptors. This review article strictly focuses on the patent literature from 2009 onwards. The structure of the potent compounds, their IC50 values, models/assays used for the anticancer evaluation and the enzymes/ receptors/ targets involved have been presented in this compilation. Significant number of patents i.e. 59 have been published on pyrimidine based anticancer agents from 2009-2014 (from 2009 through the present date) which clearly indicate that this heterocycle is an area of focus at present for researchers all over the globe. Moreover, out of the 59 patents published during this period, 32 have been published from 2012 onwards which further highlights the present interest of the researcher towards pyrimidine based anticancer agents. The promising activity displayed by these pyrimidine based scaffolds clearly places them in fore-front as potential future drug candidates. The present compilation can be extremely beneficial for the medicinal chemists working on design and synthesis of anticancer drugs.

AB - Pyrimidine ring is the building unit of DNA and RNA and thus pyrimidine based chemical architectures exhibit diverse pharmacological activities. Among the reported medicinal attributes of pyrimidines, anticancer activity is the most extensively reported. The anticancer potential of pyrimidines in fused scaffolds has also been evidenced through number of research article and patent literature. The pyrimidines based scaffolds have exerted their cell killing effects through varied mechanisms which indicate their potential to interact with diverse en-zymes/targets/receptors. This review article strictly focuses on the patent literature from 2009 onwards. The structure of the potent compounds, their IC50 values, models/assays used for the anticancer evaluation and the enzymes/ receptors/ targets involved have been presented in this compilation. Significant number of patents i.e. 59 have been published on pyrimidine based anticancer agents from 2009-2014 (from 2009 through the present date) which clearly indicate that this heterocycle is an area of focus at present for researchers all over the globe. Moreover, out of the 59 patents published during this period, 32 have been published from 2012 onwards which further highlights the present interest of the researcher towards pyrimidine based anticancer agents. The promising activity displayed by these pyrimidine based scaffolds clearly places them in fore-front as potential future drug candidates. The present compilation can be extremely beneficial for the medicinal chemists working on design and synthesis of anticancer drugs.

KW - Anticancer

KW - Chemotherapeutic agents

KW - Heterocycles

KW - Medicinal

KW - Patent

KW - Pyrimidine

UR - http://www.scopus.com/inward/record.url?scp=84920774848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920774848&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 23

EP - 71

JO - Recent Patents on Anti-Cancer Drug Discovery

JF - Recent Patents on Anti-Cancer Drug Discovery

SN - 1574-8928

IS - 1

ER -